[Agents for the metabolic correction of myocardial energy metabolism in treating patients with ischemic heart disease]

Lik Sprava. 2000 Mar:(2):26-30.
[Article in Ukrainian]

Abstract

Correction of the metabolic link of the natural course of ischemic heart disease (IHD) was found out to be a real reserve of enhancement of therapy efficiency in treating this condition. A total of 137 IHD patients were examined, presenting with functional class II-III exertional angina, their age ranging between 67 to 86 years. Kinds of metabolic complexes to be used in IHD treatment included amino acids, antioxidants, cofactors, energy-providing compounds that enhance efficiency of basic methods of IHD therapy. A positive therapeutic effect of metabolic correction treatments was evidenced by earlier dispelling of electrocardiographic signs of myocardial ischemia, higher tolerance to physical load, improvement in parameters characterizing cardio-hemodynamics.

Publication types

  • Clinical Trial
  • Comparative Study
  • English Abstract

MeSH terms

  • Aged
  • Aged, 80 and over
  • Angina Pectoris / diagnosis
  • Angina Pectoris / drug therapy
  • Angina Pectoris / metabolism
  • Angina Pectoris / physiopathology
  • Cardiovascular Agents / therapeutic use*
  • Drug Therapy, Combination
  • Energy Metabolism / drug effects*
  • Heart / drug effects*
  • Hemodynamics / drug effects
  • Humans
  • Myocardial Ischemia / diagnosis
  • Myocardial Ischemia / drug therapy*
  • Myocardial Ischemia / metabolism
  • Myocardial Ischemia / physiopathology
  • Myocardium / metabolism*

Substances

  • Cardiovascular Agents